Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edina Pallagi

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Drug Discovery Today|March 31, 2018
Extension of quality-by-design concept to the early development phase of pharmaceutical R&D processesIldikó Csóka, Edina Pallagi, Tamás L Paál
Acta Pharmaceutica Hungarica|July 29, 2004
[Thermostability testing of iron(II) sulphate for formulation of drug product]Orsolya Laczkovich, Piroska Révész, Edina Pallagi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 22, 2019
Pegylation and formulation strategy of Anti-Microbial Peptide (AMP) according to the quality by design approachReihaneh Manteghi, Edina Pallagi, Gábor Olajos, et al.
Current Medicinal Chemistry|April 7, 2021
Regulatory Considerations, Challenges and Risk-based Approach in Nanomedicine DevelopmentIldikó Csóka, Ruba Ismail, Orsolya Jójárt-Laczkovich, et al.
Pharmaceutics|December 2, 2020
A Proposed Methodology for a Risk Assessment-Based Liposome Development ProcessZsófia Németh, Edina Pallagi, Dorina Gabriella Dobó, et al.
International Journal of Pharmaceutics|July 3, 2015
Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulationEdina Pallagi, Rita Ambrus, Piroska Szabó-Révész, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 28, 2006
Development of spherical iron(II) sulfate heptahydrate-containing solid particles with sustained drug releasePiroska Szabó-Révész, Béla Farkas, Tamás Gregor, et al.
Drug Design, Development and Therapy|October 28, 2016
Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approachKeyhaneh Karimi, Edina Pallagi, Piroska Szabó-Révész, et al.
International Journal of Pharmaceutics|December 26, 2006
Study of thermal behaviour of sugar estersAngéla Szuts, Edina Pallagi, Géza Regdon, et al.
International Journal of Pharmaceutics|July 9, 2016
New aspects of developing a dry powder inhalation formulation applying the quality-by-design approachEdina Pallagi, Keyhaneh Karimi, Rita Ambrus, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|March 31, 2018
Extension of quality-by-design concept to the early development phase of pharmaceutical R&D processesIldikó Csóka, Edina Pallagi, Tamás L Paál
Acta Pharmaceutica Hungarica|July 29, 2004
[Thermostability testing of iron(II) sulphate for formulation of drug product]Orsolya Laczkovich, Piroska Révész, Edina Pallagi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 22, 2019
Pegylation and formulation strategy of Anti-Microbial Peptide (AMP) according to the quality by design approachReihaneh Manteghi, Edina Pallagi, Gábor Olajos, et al.
Current Medicinal Chemistry|April 7, 2021
Regulatory Considerations, Challenges and Risk-based Approach in Nanomedicine DevelopmentIldikó Csóka, Ruba Ismail, Orsolya Jójárt-Laczkovich, et al.
Pharmaceutics|December 2, 2020
A Proposed Methodology for a Risk Assessment-Based Liposome Development ProcessZsófia Németh, Edina Pallagi, Dorina Gabriella Dobó, et al.
International Journal of Pharmaceutics|July 3, 2015
Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulationEdina Pallagi, Rita Ambrus, Piroska Szabó-Révész, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 28, 2006
Development of spherical iron(II) sulfate heptahydrate-containing solid particles with sustained drug releasePiroska Szabó-Révész, Béla Farkas, Tamás Gregor, et al.
Drug Design, Development and Therapy|October 28, 2016
Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approachKeyhaneh Karimi, Edina Pallagi, Piroska Szabó-Révész, et al.
International Journal of Pharmaceutics|December 26, 2006
Study of thermal behaviour of sugar estersAngéla Szuts, Edina Pallagi, Géza Regdon, et al.
International Journal of Pharmaceutics|July 9, 2016
New aspects of developing a dry powder inhalation formulation applying the quality-by-design approachEdina Pallagi, Keyhaneh Karimi, Rita Ambrus, et al.
Pageof 3